Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017
Published Date: 2/5/2026
Rule
Summary
Starting March 9, 2026, emergency medical services (EMS) agencies must register under new rules that make it easier and safer to handle emergency medicines like controlled substances. These changes let EMS pros give important meds without a doctor right there, while keeping better track of storage and delivery. This update affects EMS agencies nationwide and helps patients get faster, safer care without extra costs.
Analyzed Economic Effects
6 provisions identified: 4 benefits, 0 costs, 2 mixed.
EMS Can Administer Controlled Drugs Without Doctor Present
Starting March 9, 2026, emergency medical services professionals of a registered EMS agency may administer controlled substances in Schedules II–V outside the physical presence of a medical director if State law allows and the administration is done pursuant to valid standing or verbal orders. This change is intended to let EMS personnel give needed emergency medicines more quickly at the scene or during transport.
New State-Level EMS Registration
If you run or operate an EMS agency, the rule creates a new DEA registration category for EMS agencies and lets an agency obtain a single DEA registration for each State in which it operates instead of registering each separate location. The rule also requires an EMS agency to be registered in every State where it administers controlled substances.
Jump Bags and Carrying During Active Response
The rule allows EMS personnel to carry controlled substances on their person or in a jump bag while they are actively responding to an emergency, and such items are not treated as 'stored' during that active response. Controlled substances carried this way must be returned to approved secure storage when personnel are not engaged in a response.
Storage, Locking, and Vehicle Security Rules
The rule requires registered EMS agencies to store controlled substances in a securely locked, substantially constructed cabinet or safe or an automated dispensing machine, and EMS vehicles storing controlled substances must be locked when parked outside an enclosed registered or designated location unless personnel are present or at the scene of an emergency. Controlled substances must be kept in locked, non-removable storage when vehicles are unattended.
Recordkeeping ID Rule Made Flexible
If your EMS agency keeps records of controlled substance administrations, the rule requires records to reflect the last name or initials (not mandatory personal initials) of the person who administered the drug, the medical director or authorizing professional, the person who disposed of a drug, and any witness. The rule also requires EMS agencies to retain records of administrations, disposals, acquisitions, distributions, and deliveries and make them readily retrievable.
Licensing and Restock Flexibility
The rule requires EMS personnel who administer controlled substances to be licensed or certified by the State in which they practice. The rule also allows EMS vehicles to restock controlled substances at hospitals other than the hospital whose registration the EMS vehicle is using, provided the restock conditions and recordkeeping in Sec. 1307.14 are met.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06523 — Designation of P2P Methyl Glycidic Acid as a List I Chemical
Starting May 4, 2026, anyone handling P2P methyl glycidic acid—a key chemical used to make illegal drugs like methamphetamine—must follow new government rules and register with the DEA. This means all transactions, big or small, will be closely watched to stop illegal drug production. Businesses dealing with this chemical should act fast to stay legal and avoid penalties.
2026-06521 — Importer of Controlled Substances Application: Lipomed/LGC Standards
Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.
2026-06051 — Importer of Controlled Substances Application: Usona Institute
Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.
2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!
2026-05618 — Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.
2026-05486 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!
Previous / Next Documents
Previous: 2026-02284 — Fisheries of the Exclusive Economic Zone Off Alaska; Pacific Cod by Catcher Vessels Greater Than or Equal to 60 Feet (18.3 Meters) Length Overall Using Pot Gear in the Bering Sea and Aleutian Islands Management Area
Starting February 4, 2026, fishing for Pacific cod using pot gear is temporarily banned for catcher vessels 60 feet or longer in the Bering Sea and Aleutian Islands. This stop helps keep the 2026 catch limits from being broken, protecting fish stocks and the fishing industry. The closure lasts until September 1, 2026, so big boats need to plan their fishing carefully to avoid penalties.
Next: 2026-02290 — Reef Fish Fishery of the Gulf of America; 2026 Commercial Accountability Measure for Gulf of America Greater Amberjack
Fishermen who catch greater amberjack in the Gulf of America will face lower catch limits in 2026 because they caught too many fish in 2025. The government is cutting the allowed commercial catch by 8,184 pounds to help protect the amberjack population. This new rule starts February 5, 2026, and lasts through the end of the year, keeping the fishery healthy for the future.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in